Monfort
Mon4t is a digital health company that transforms any standard smartphone into a sophisticated neurological medical testing device. Their FDA-cleared, HIPAA- and GDPR-compliant platform provides clinicians, telemedicine providers, pharmaceutical companies, hospitals, and researchers with clinically validated tools for remote and in-person testing and monitoring of neurological and psychiatric patients. The app delivers comprehensive insights into cognitive, motor, and affective functions, enabling early diagnosis and continuous monitoring of diseases such as Parkinson's, Huntington's, and Alzheimer's. Mon4t leverages AI and machine learning to provide objective biomarkers and continuous passive and active monitoring, improving medical decision-making and patient care while expanding access to neurological evaluation globally. The company has demonstrated efficacy through over 20 peer-reviewed clinical studies and is used by hospitals and research institutions worldwide, including Queen Mary Hospital in Hong Kong and Universidade Eduardo Mondlane in Mozambique. Mon4t's business model includes SaaS and subscription services compatible with existing insurance billing codes, generating revenue without requiring investment in equipment or AI by clients.
Monfort
Mon4t is a digital health company that transforms any standard smartphone into a sophisticated neurological medical testing device. Their FDA-cleared, HIPAA- and GDPR-compliant platform provides clinicians, telemedicine providers, pharmaceutical companies, hospitals, and researchers with clinically validated tools for remote and in-person testing and monitoring of neurological and psychiatric patients. The app delivers comprehensive insights into cognitive, motor, and affective functions, enabling early diagnosis and continuous monitoring of diseases such as Parkinson's, Huntington's, and Alzheimer's. Mon4t leverages AI and machine learning to provide objective biomarkers and continuous passive and active monitoring, improving medical decision-making and patient care while expanding access to neurological evaluation globally. The company has demonstrated efficacy through over 20 peer-reviewed clinical studies and is used by hospitals and research institutions worldwide, including Queen Mary Hospital in Hong Kong and Universidade Eduardo Mondlane in Mozambique. Mon4t's business model includes SaaS and subscription services compatible with existing insurance billing codes, generating revenue without requiring investment in equipment or AI by clients.